← Back to front page
United States · Markets & Finance · CNBC

People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study

Published by CNBC · United States 3 h ago

The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for more convenient treatments.

Read the full article on CNBC Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbc.com)

Also worth reading